| A | B | C | D | E | F |
---|---|---|---|---|---|---|
Reputational benefit | Â | Â | Â | Â | Â | Â |
Perception of firm by consumers | X | X | X | X | Â | Â |
Perception of firm by potential funders | Â | Â | Â | X | Â | Â |
Relationship and trust building with potential partners and stakeholders | X | X | Â | Â | Â | X |
Employee recruitment, satisfaction, engagement and innovation | X | X | Â | X | X | Â |
Ranking on Dow Jones Sustainability Index* | Â | Â | Â | X | X | X |
Competetive advantage | Â | Â | Â | Â | Â | Â |
Entering new markets | X | Â | X | X | X | X |
Expanding consumer base | Â | Â | Â | Â | Â | X |
Intelligence gathering on new markets | Â | X | Â | Â | Â | Â |
Anticipated long-term financial gain | X | Â | X | X | Â | X |
Increased cost-effectiveness of interventions and programs (in developing countries) | Â | Â | X | Â | Â | Â |
Improved efficiencies | Â | Â | Â | Â | X | Â |
Opportunity for innovation | X | Â | Â | Â | Â | X |
Special access to local government officials and decision making | Â | Â | Â | X | Â | Â |
Philanthropy & health impact | Â | Â | Â | Â | Â | Â |
Obligation as a health care company | Â | Â | Â | X | Â | X |
Improved population health impact | X | X | X | X | X | X |
Increasing patient access to necessary medications/health services | X | X | X | X | X | X |